NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

末梢神經病變治療的市場規模:類型,治療(藥物療法,非藥物療法),各流通管道,各地區-尺寸,佔有率,預測,及機會分析,2020年-2027年

Peripheral Neuropathy Treatment Market, by Type, by Treatment (Pharmacological Therapies and Non-pharmacological Therapies, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 980048
出版日期 內容資訊 英文 205 Pages
商品交期: 2-3個工作天內
價格
末梢神經病變治療的市場規模:類型,治療(藥物療法,非藥物療法),各流通管道,各地區-尺寸,佔有率,預測,及機會分析,2020年-2027年 Peripheral Neuropathy Treatment Market, by Type, by Treatment (Pharmacological Therapies and Non-pharmacological Therapies, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月31日內容資訊: 英文 205 Pages
簡介

全球周圍神經病治療市場的增長因素包括人口老齡化增加。根據世界衛生組織(WHO)2018年2月發布的一篇文章,在2015年至2050年期間,世界老年人口比例將從12%幾乎翻倍至22%。此外,糖尿病病例的增加有望推動市場的增長。根據國際糖尿病聯盟(IDF)發表的一篇文章,2017年全球18-99歲糖尿病患者的估計人數約為4.25億。

本報告提供全球末梢神經病變治療市場的相關調查,提供市場規模和佔有率,市場機會和趨勢,成長及阻礙因素,類型·治療·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的·前提條件

第2章 市場展望

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各類型
    • 市場明細:不同治療
    • 市場明細:各流通管道
    • 市場明細:各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 償付方案
  • 流行病學
  • PEST分析
  • 法規方案
  • 新產品的銷售
  • 合作與契約
  • 市場趨勢

第4章 COVID-19疫情的影響

  • COVID-19市場方案
  • COVID-19對末梢神經病變治療藥市場帶來的影響

第5章 市場分析:各類型(2016-2027)

  • 簡介
  • 糖尿病性末梢神經病變
  • 化療誘發性末梢神經病變
  • 特發性末梢神經病變
  • 其他

第6章 市場分析:不同治療(2016-2027)

  • 簡介
  • 藥物療法
  • 非藥物療法

第7章 市場分析:各流通管道(2016-2027)

  • 簡介
  • 醫院和診所
  • 門診中心
  • 其他

第8章 市場分析:各地區(2016-2027)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Abbott
    • Bristol Myers Squibb
    • Cipla Limited
    • Eli Lilly and Company
    • GlaxoSmithKline plc.
    • Lupin Limited
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Dr. Reddy's Laboratories
    • Mylan NV
    • Johnson & Johnson Services Inc.
    • Teva Pharmaceutical Industries Ltd.

第10章 分析師的見解

第11章 章節

目錄

Title:
Peripheral Neuropathy Treatment Market, by Type (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), by Treatment (Pharmacological Therapies (Pain Relievers, Anti-seizure Medications, and Antidepressants) and Non-pharmacological Therapies (Transcutaneous Electrical Nerve Stimulation, Plasma Exchange and Intravenous Immune Globulin, and Others), by Distribution Channel (Hospitals and Clinics, Ambulatory Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Peripheral neuropathy is a disorder that affects the peripheral nerves. Peripheral neuropathy has a variety of systemic, metabolic, and toxic causes, for instance diabetes in metabolic cause. The most common treatable causes include diabetes mellitus, hypothyroidism, and nutritional deficiencies. The diagnosis require careful clinical assessment, judicious laboratory testing, and electro diagnostic studies or nerve biopsy, if the diagnosis remains unclear.

Market Dynamics

Rising aging population is expected to drive the global peripheral neuropathy treatment market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, reports that between 2015 and 2050, the proportion of the worldwide geriatric population will nearly double from 12% to 22%.

Moreover, rising diabetic cases is expected to drive the market growth. For instance, according to an article published by the International Diabetes Federation (IDF), in 2017, the estimated number of 18 to 99 year old diabetic patients was around 425 million globally.

researched

medicinal properties of cannabis and its derivatives are widely

Researched

Medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

Key features of the study:

  • This report provides in-depth analysis of the global peripheral neuropathy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global peripheral neuropathy treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Abbott, Bristol Myers Squibb, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc., Lupin Limited, Merck and Co. Inc., Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories, Mylan NV, Johnson & Johnson Services Inc., and Teva Pharmaceutical Industries Ltd, among others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global peripheral neuropathy treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral neuropathy treatment market.

Detailed Segmentation:

  • Global Peripheral Neuropathy Treatment Market, By Type:
    • Diabetic Peripheral Neuropathy
    • Chemotherapy-induced Peripheral Neuropathy
    • Idiopathic Peripheral Neuropathy
    • Others
  • Global Peripheral Neuropathy Treatment Market, By Treatment:
    • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
    • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
  • Global Peripheral Neuropathy Treatment Market, By Distribution Channel:
    • Hospitals and Clinics
    • Ambulatory Centers
    • Others
  • Global Peripheral Neuropathy Treatment Market, By Region:
    • North America
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bristol Myers Squibb
    • Cipla Limited
    • Eli Lilly and Company
    • GlaxoSmithKline plc.
    • Lupin Limited
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Dr. Reddy's Laboratories
    • Mylan NV
    • Johnson & Johnson Services Inc.
    • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Peripheral Neuropathy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Peripheral Neuropathy Treatment Products

5. Global Peripheral Neuropathy Treatment Market, By Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Diabetic Peripheral Neuropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Chemotherapy-induced Peripheral Neuropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Idiopathic Peripheral Neuropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Peripheral Neuropathy Treatment Market, By Treatment, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pharmacological Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Pain Relievers
    • Anti-seizure Medications
    • Antidepressants
  • Non-pharmacological Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Transcutaneous Electrical Nerve Stimulation
    • Plasma Exchange and Intravenous Immune Globulin
    • Others

7. Global Peripheral Neuropathy Treatment Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ambulatory Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Peripheral Neuropathy Treatment Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Abbott
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cipla Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lupin Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck and Co. Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan NV
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson Services Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

10. Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact